Fibrocell’s gene therapy candidate FCX-013 nabs Rare Pediatric Disease Designation from FDA; shares ahead 9 … – Seeking Alpha
|
Fibrocell's gene therapy candidate FCX-013 nabs Rare Pediatric Disease Designation from FDA; shares ahead 9 …
Seeking Alpha Thinly traded nano cap Fibrocell Science (NASDAQ:FCSC) perks up 9% premarket on light volume in response to its announcement that the FDA has granted Rare Pediatric Disease Designation to Orphan Drug-tagged FCX-013, a gene therapy candidate for … Fibrocell Receives Rare Pediatric Disease Designation from FDA for FCX-013 for Treatment of Localized Scleroderma Analysts Offer Predictions for Fibrocell Science Inc's FY2020 Earnings (FCSC) |
